Clinical Trial Update: FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical study evaluating FES imaging to optimize tamoxifen therapy in estrogen receptor–positive metastatic breast cancer, including ESR1 mutati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• 18F-fluoroestradiol (FES) (fluoroestradiol)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: ERα+ Breast Cancer, ESR1 Gene Mutation | EARLY_Phase 1 | Status: RECRUITING